Cargando…
270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy
BACKGROUND: To evaluate the therapeutic efficacy of omalizumab and specific subcutaneous immunotherapy (SCIT) as a treatment modality in patients with more than one allergic-type condition. METHODS: In the first group (Group A), 2 males and 7 females with severe persistent asthma and a mean age of 3...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512926/ http://dx.doi.org/10.1097/01.WOX.0000412027.16513.76 |